Royalty Pharma (NASDAQ:RPRX) Upgraded by Wall Street Zen to “Buy” Rating
Royalty Pharma (NASDAQ:RPRX – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Saturday. RPRX has been the subject of several other reports. Citigroup restated a “buy” rating on shares of Royalty Pharma in a research report on Friday, […]
Royalty Pharma (NASDAQ:RPRX – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Saturday. RPRX has been the subject of several other reports. Citigroup restated a “buy” rating on shares of Royalty Pharma in a research report on Friday, […]
